View the NEXOPIL-20 registration information details.
Back to drug list
ItemsDrug Registration information
ID2428
No2428
Brand NameNEXOPIL-20
IngredientsESOMEPRAZOLE MAGNESIUM TRIHYDRATE IP EQ.TO ESOMEPRAZOLE 20 MG
Dosage FormTABLET
Primary PackagingALU-ALU STRIP
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, IN COMBINATION WITH APPROPRIATE ANTIBACTERIAL THERAPEUTIC REGIMENS FOR ERADICATION AND HEALING OF H.PYLORI ASSOCIATED DUODENAL ULCER, PATIENTS REQUIRING CONTINUED NSAID THERAPY, TREATMENT OF ZOLLINGER ELLISON SYNDROME.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionCHOCOLATE COLOURED, ROUND, BICONVEX,ENTERIC COATED TABLET
Note
License OwnerTHC SOLE CO.,LTD
ManufacturerPSYCHOTROPICS INDIA LIMITED
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4410/18
FDD Registration Date03/03/2025
Expiry Date02/03/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA